Changes in C-reactive protein and haptoglobin in dogs with lymphatic neoplasia

Veterinary Journal

Volumn 174, Issue 1, 2007, Pages 188-192

  Mischke, R ^a,b   Waterston, M ^b   Eckersall, P D ^b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b Faculty of Veterinary Medicine   (United Kingdom)

Author keywords

Acute phase protein; C reactive protein; Dog; Haptoglobin; Leukaemia; Lymphoma; Myeloma

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; HAPTOGLOBIN; HEMOGLOBIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE PHASE RESPONSE; ARTICLE; CANCER GRADING; CHRONIC LYMPHATIC LEUKEMIA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOLOGIC MALIGNANCY; KRUSKAL WALLIS TEST; LYMPHOMA; MULTIPLE MYELOMA; NONHUMAN; PROTEIN BINDING; PROTEIN BLOOD LEVEL;

ANIMALS; C-REACTIVE PROTEIN; DOG DISEASES; DOGS; HAPTOGLOBINS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA; MULTIPLE MYELOMA;

CANIS FAMILIARIS;

EID: 34249890816     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2006.05.018     Document Type: Article

References (29)

1. Agrawal A. CRP after 2004. Molecular Immunology 42 (2005) 927-930
2. Alexandrakis M.G., Passam F.H., Ganotakis E.S., Sfiridaki K., Xilouri I., Perisinakis K., and Kyriakou D.S. The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma. Clinical and Laboratory Haematology 25 (2003) 41-46
3. Bayer L., Schöntube M., and Dörffel W. CRP, IL-6 und PCT als Infektionsparameter bei onkologisch kranken Kindern. (C-reactive protein, interleukin-6 and procalcitonin as parameters of infection in pediatric patients with oncologic diseases). Klinische Pädiatrie 212 (2000) 326-331
4. Cerón J.J., Eckersall P.D., and Martinez-Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Veterinary Clinical Pathology 34 (2005) 85-99
5. Correa S.S., Mauldin G.N., Mauldin G.E., and Mooney S.C. Serum alpha 1-acid glycoprotein concentration in cats with lymphoma. Journal of the American Animal Hospital Association 37 (2001) 153-158
6. Diamandis E.P., and Van der Merwe D.-E. Plasma protein profiling by mass spectrometry for cancer diagnosis: opportunities and limitations. Clinical Cancer Research 11 (2005) 963-965
7. Eckersall P.D., Duthie S., Safi S., Moffatt D., Horadagoda N.U., Doyle S., Parton R., Bennett D., and Fitzpatrick J.L. An automated biochemical for haptoglobin: prevention of interference from albumin. Comparative Haematology International 5 (1999) 117-121
8. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 340 (1999) 448-454
9. Gambacorti-Passerini C., Zucchetti M., Russo D., Frapolli R., Verga M., Bungaro S., Tornaghi L., Rossi F., Pioltelli P., Pogliani E., Alberti D., Corneo G., and D'Ìncalci M. Alpha 1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients. Clinical Cancer Research 9 (2003) 625-632
10. 1-acid glycoprotein to monitor therapy of cancer patients. Journal of the National Cancer Institute 71 (1983) 25-30
11. 1-acid glycoprotein concentrations before and after relapse in dogs with lymphoma treated with doxorubicin. Journal of the American Veterinary Medical Association 214 (1999) 1023-1025
12. Heinrich P.C., Castell J.C., and Andus T. Interleukin-6 and the acute phase response. Biochemical Journal 265 (1990) 621-636
13. Jergens A.E., Schreiner C.A., Frank D.E., Niyo Y., Ahrens F.E., Eckersall P.D., Beson T.J., and Evans R. A scoring index for disease activity in canine inflammatory bowel disease. Journal of Veterinary Internal Medicine 17 (2003) 291-297
14. Klein B., and Bataille R. Cytokine network in human multiple myeloma. Hematology/Oncology Clinics of North America 6 (1992) 273-284
15. Kovtunova M.E., Pan'kov V.N., and Perevalova N.N. (Ceruloplasmin and peptides of medium molecular weight as parameters in development of acute myeloblastic leukemia). Klinicheskaia Laboratornaia Diagnostika 2003 (2003) 52-54
16. Larghero J., Leguay T., Mourah S., Madelaine-Chambrin I., Taskin A.L., Raffoux E., Bastie J.N., Degos L., Berthaud P., Marolleau J.P., Calvo F., Chomienne C., Mahon F.X., and Rousselot P. Relationship between elevated levels of the alpha 1 acid glycoprotein in chronic myelogenous leukaemia in blast crisis and pharmacological resistance to imatinib (Gleevec) in vitro and in vivo. Biochemical Pharmacology 66 (2003) 1907-1913
17. Le Coutre P., Kreuzer K.A., Na I.K., Lupberger J., Holdhoff M., Appelt C., Schwarz M., Muller C., Gambacorti-Passerini C., Platzbecker U., Bonnet R., Ehninger G., and Schmidt C.A. Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukaemia during the first 13 weeks of therapy with STI571. Blood Cells Molecules & Diseases 28 (2002) 75-85
18. Legouffe E., Rodriguez C., Picot M.C., Richard B., Klein B., Rossi J.F., and Commes T. C-reactive protein serum level is a valuable and simple prognostic marker in non-Hodgkin's lymphoma. Leukemia and Lymphoma 31 (1998) 351-357
19. Macia J., Gomez X., Esquerda A., Perez B., Callao V., and Marzo C. Value of the determination of TNF-alpha in the plasma of patients with non-Hodgkin's lymphoma. Leukemia and Lymphoma 20 (1996) 481-486
20. Murata H., Shimada N., and Yoshioka M. Current research on acute phase proteins in veterinary diagnosis: an overview. The Veterinary Journal 168 (2004) 28-40
21. Nakagawa-Tosa N., Morimatsu M., Kawasaki M., Nakatsuji H., Syuto B., and Saito M. Stimulation of haptoglobin synthesis by interleukin-6 and tumor necrosis factor, but not by interleukin-1, in bovine primary cultured hepatocytes. The Journal of Veterinary Medical Science 57 (1995) 219-223
22. 1-acid acid glycoprotein in dogs with malignant neoplasia. Journal of the American Veterinary Medical Association 203 (1993) 1144-1146
23. Owen L.N. TNM classification of tumors in domestic animals (1981), World Health Organisation, Geneva
24. Pedersen L.M., and Sørensen P.G. Mediators of inflammation correlate with microalbuminuria in patients with non-Hodgkin's lymphoma. British Journal of Haematology 121 (2003) 275-279
25. Petersen H.H., Nilesen J.P., and Heegaard P.M. Application of acute phase protein measurements in veterinary clinical chemistry. Veterinary Research 35 (2004) 163-187
26. Vermeire S., Van Assche G., and Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflammatory Bowel Diseases 10 (2004) 661-665
27. Warzocha K., Salles G., Bienvenu J., Barbier Y., Bastion Y., Doche C., Rieux C., and Coiffier B. Prognostic significance of TNF alpha and its soluble receptor in malignant lymphomas. Leukemia 11 (1997) 441-443
28. Wieland A., Kerbl R., Berghold A., Schwinger W., Mann G., and Urban C. C-reactive protein (CRP) as tumour marker in pediatric and adolescent patients with Hodgkin disease. Medical and Pediatric Oncology 41 (2003) 21-25
29. Yaǧci M., Sucak G.T., and Haznedar R. Fibrinolytic activity in multiple myeloma. American Journal of Hematology 74 (2003) 231-237